Effects of levodopa and deep brain stimulation on motor speech performance in Parkinson's disease

Basal Ganglia

Volumn 2, Issue 1, 2012, Pages 49-54

  Skodda, Sabine ^a   Schlegel, Uwe ^a   Südmeyer, Martin ^b   Schnitzler, Alfons ^b   Wojtecki, Lars ^b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Motor speech performance executive function; Parkinson's disease; Subthalamic deep brain stimulation; Syllable repetition

Indexed keywords

LEVODOPA;

ADULT; AGED; ARTICLE; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG EFFECT; EXECUTIVE FUNCTION; FEMALE; HUMAN; LANGUAGE ABILITY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; SPEECH ANALYSIS; SPEECH DEVELOPMENT; SUBTHALAMIC NUCLEUS; TASK PERFORMANCE; THERAPY EFFECT;

EID: 84858073628     PISSN: 22105336     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.baga.2012.01.001     Document Type: Article

References (65)

1. Iansek R., Bradshaw J.L., Morris M.E. Interaction of the basalganglia and supplementary motor area in the elaboration of movements. Motor control and sensory motor integration: issues and directions 1995, 7-59. Elsevier Science BV, Amsterdam, Netherlands. D.J. Glencross, J.P. Piek (Eds.).
2. O'Boyle D.J., Freeman J.S., Cody F.W. The accuracy and precision of timing of self-paced, repetitive movements in subjects with Parkinson's disease. Brain 1996, 119:51-70.
3. Yahalom G., Simon E.S., Thorne R., Peretz C., Giladi N. Hand rhythmic tapping and timing in Parkinson's disease. Parkinsonism Relat Disord 2004, 10:143-148.
4. Takakusaki K., Tomita N., Yano M. Substrates for normal gait and pathophysiology of gait disturbances with respect to the basal ganglia dysfunction. J Neurol 2008, 255(Suppl. 4):19-29.
5. Oliveira R.M., Gurd J.M., Nixon P., Marshall J.C., Passingham R.E. Mov Disord 1998, 3:422-427.
6. Almeida Q.J., Wishart L.R., Lee T.D. Bimanual coordination deficits with Parkinson's disease: the influence of movement speed and external cueing. Mov Disord 2002, 17:30-37.
7. Ho A., Iansek R., Marigliani C., Bradshaw J.L., Gates S. Speech impairment in a large sample of people with Parkinson's disease. Behav Neurol 1998, 11:131-137.
8. Canter G.J. Speech characteristics of patients with Parkinson's disease: I. Intensity, pitch, and duration. J Speech Hear Disord 1963, 28:221-229.
9. Darley F.L., Aronson A.E., Brown J.R. Clusters of deviant speech dimensions in the dysarthrias. J Speech Hear Res 1969, 12:462-496.
10. Metter J., Hanson W. Clinical and acoustical variability in hypokinetic dysarthria. J Commun Disord 1986, 19:347-366.
11. Ludlow C., Connor N., Bassich C. Speech timing in Parkinson's and Huntington's disease. Brain Lang 1987, 32:195-214.
12. Caligiuri M.P. The influence of speaking rate on articulatory hypokinesia in Parkinsonian dysarthria. Brain Lang 1989, 36:493-502.
13. Skodda S., Schlegel U. Speech rate and rhythm in Parkinson's disease. Mov Disord 2008, 23:985-992.
14. Logigian E., Hefter H., Reiners K.H., Freund H.J. Does tremor pace repetitive voluntary motor behaviour in Parkinson's disease ?. Ann Neurol 1991, 30:172-179.
15. Ackermann H., Konczak J., Hetrich I. The temporal control of repetitive articulatory movements in Parkinson's disease. Brain Lang 1997, 56:312-319.
16. Skodda S., Flasskamp A., Schlegel U. Instability of syllable repetition as a model for impaired motor processing: is Parkinson's disease a " rhythm disorder" ?. J Neural Transm 2010, 117:605-612.
17. De Letter M., Santens P., De Bodt M., Boon P., Van Borsel J. Levodopa-induced alterations in speech rate in advanced Parkinson's disease. Acta Neurol Belg 2006, 106:19-22.
18. Ho A.K., Bradshaw J.L., Iansek R. For better or worse: the effect of levodopa on speech in Parkinson's disease. Mov Disord 2008, 23:575-580.
19. Skodda S., Visser W., Schlegel U. Short- and long-term dopaminergic effects on dysarthria in early Parkinson's disease. J Neural Transm 2010, 117:197-205.
20. Limousin P., Pollak P., Benazzouz A., Hoffman D., Le Bas J.F., Brousolle E., et al. Effect of Parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 1995, 345:91-95.
21. Limousin P., Krack P., Pollak P., Benazzouz A., Ardouin C., Hoffmann D., et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 1998, 339:1105-1111.
22. Krack P., Batir A., Van Blercom N., Chabardes S., Fraix V., Ardouin C., et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 2003, 349:1925-1934.
23. Fasano A., Romito L.M., Daniele A., Piano C., Zinno M., Bentivoglio A.R., et al. Motor and cognitive outcome in patients with Parkinson's disease 8years after subthalamic implants. Brain 2010, 133:2664-2676.
24. Deuschl G., Herzog J., Kleiner-Fisman G., Kubu C., Lozano A.M., Lyons K.E. Deep brain stimulation: postoperative issues. Mov Disord 2006, 21(Suppl.1):S219-S237.
25. Guehl D., Cuny E., Benazzouz A., Rougier A., Tison F., Machado S., et al. Side-effects of subthalamic stimulation in Parkinson's disease: clinical evolution and predictive factors. Eur J Neurol 2006, 13:963-971.
26. Tripoliti E., Zrinzo L., Martinez-Torres I., Tisch S., Frost E., Borrell E., et al. Effects of contact location and voltage amplitude on speech and movement in bilateral subthalamic nucleus deep brain stimulation. Mov Disord 2008, 23:2377-2383.
27. Tommasi G., Krack P., Fraix V., Le Bas J.F., Chabardes S., Benabid A.L., et al. Pyramidal tract side effects induced by deep brain stimulation of the subthalamic nucleus. J Neurol Neurosurg Psychiatry 2008, 79:813-819.
28. Kleiner-Fisman G., Fisman D.N., Zamir O., Dostrovsky J.O., Sime E., Saint-Cyr J.A., et al. Subthalamic nucleus deep brain stimulation for Parkinson's disease after successful pallidotomy: clinical and electrophysiological observations. Mov Disord 2004, 19:1209-1214.
29. Gentil M., Garcia-Ruiz P., Pollak P., Benabid A.L. Effect of bilateral deep-brain stimulation on oral control of patients with parkinsonism. Eur Neurol 2000, 44:147-152.
30. Gentil M., Chauvin P., Pinto S., Pollak P., Benabid A.L. Effect of bilateral stimulation of the subthalamic nucleus on Parkinsonian voice. Brain Lang 2001, 78:233-240.
31. Pinto S., Gentil M., Fraix V., Benabid A.L., Pollak P. Bilateral subthalamic stimulation effects on oral force control in Parkinson's disease. J Neurol 2003, 250:179-187.
32. Rousseaux M., Krystkowiak P., Kozlowski O., Ozsancak C., Blond S., Destee A. Effects of subthalamic nucleus stimulation on Parkinsonian dysarthria and speech intelligibility. J Neurol 2004, 251:327-334.
33. Klostermann F., Ehlen F., Vesper J., Nubel K., Gross M., Marzinzik F., et al. Effects of subthalamic deep brain stimulation on dysarthrophonia in Parkinson's disease. J Neurol Neurosurg Psychiatry 2008, 79:522-529.
34. Skodda S., Flasskamp A., Schlegel U. Instability of syllable repetition in Parkinson's disease - influence of levodopa and deep brain stimulation. Mov Disord 2011, 26:728-730.
35. Hughes A.J., Ben-Shlomo Y., Daniel S.E., Lees A.J. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicalpathologic study. Neurology 1992, 42:1142-1146.
36. Wu T., Hallett M. A functional MRI study of automatic movements in patients with Parkinson's disease. Brain 2005, 128:2250-2259.
37. Wu T., Chan P., Hallett M. Effective connectivity of neural networks in automatic movements in Parkinson's disease. Neuroimage 2010, 49:2581-2587.
38. Yu H., Sternad D., Corcos D.M., Vaillancourt D.E. Role of hyperactive cerebellum and motor cortex in Parkinson's disease. Neuroimage 2007, 35:222-233.
39. Benecke R., Rothwell J.C., Dick J.P., Day B.L., Marsden C.D. Performance of simultaneous movements in patients with Parkinson's disease. Brain 1986, 109:739-757.
40. Castiello U., Bennett K.M. The bilateral reach-to-grasp movement of Parkinson's disease subjects. Brain 1997, 120:593-604.
41. Brown R.G., Marsden C.D. Dual task performance and processing resources in normal subjects and patients with Parkinson's disease. Brain 1991, 114:215-231.
42. Oliveira R.M., Gurd J.M., Nixon P., Marshall J.C., Passingham R.E. Hypometriain Parkinson's disease: automatic vs. controlled processing. Mov Disord 1998, 13:422-427.
43. Price A., Shin J.C. The impact of Parkinson's disease on sequence learning: perceptual pattern learning and executive function. Brain Cogn 2009, 69:252-261.
44. Lima C.F., Meireles L.P., Fonseca R., Castro S.L., Garrett C. The Frontal Assessment Battery (FAB) in Parkinson's disease and correlations with formal measures of executive functioning. J Neurol 2008, 255:1756-1761.
45. Brauer S.G., Morris M.E. Can people with Parkinson's disease improve dual tasking when walking?. Gait Posture 2010, 31:229-233.
46. Plotnik M., Giladi N., Hausdorff J.M. Bilateral coordination of gait and Parkinson's disease: the effects of dual tasking. J Neurol Neurosurg Psychiatry 2009, 80:347-350.
47. Plaha P., Ben-Shlomo Y., Patel N.K., Gill S.S. Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism. Brain 2006, 129(Part 7):1732-1747.
48. McIntyre C.C., Savasta M., Walter B.L., Vitek J.L. How does deep brain stimulation work? Present understanding and future questions. J Clin Neurophysiol 2004, 21:40-50.
49. Tripoliti E., Zrinzo L., Martinez-Torres I., Frost E., Pinto S., Foltynie T., et al. Effects of subthalamic stimulation on speech of consecutive patients with Parkinson disease. Neurology 2011, 76(1):80-86.
50. Wojtecki L., Timmermann L., Jörgens S., Südmeyer M., Maarouf M., Treuer H., et al. Frequency-dependent reciprocal modulation of verbal fluency and motor functions in subthalamic deep brain stimulation. Arch Neurol 2006, 63:1273-1276.
51. Kalbe E., Voges J., Weber T., Haarer M., Baudrexel S., Klein J.C., et al. Frontal FDG-PET activity correlates with cognitive outcome after STN-DBS in Parkinson disease. Neurology 2009, 72:42-49.
52. Halpern C.H., Rick J.H., Danish S.F., Grossman M., Baltuch G.H. Cognition following bilateral deep brain stimulation surgery of the subthalamic nucleus for Parkinson's disease. Int J Geriatr Psychiatry 2009, 24:443-451.
53. Schroeder U., Kuehler A., Lange K.W., Haslinger B., Tronnier V.M., Krause M. Subthalamic nucleus stimulation affects a frontotemporal network: a PET study. Ann Neurol 2003, 54:445-450.
54. Rodriquez-Oroz M.C., Obeso J.A., Lang A.E., Houeto J.L., Pollak P., et al. Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4years follow-up. Brain 2005, 128:2240-2259.
55. Alberts J.L., Voelcker-Rehage C., Hallahan K., Vitek M., Bamzai R., Vitek J.L. Bilateral subthalamic stimulation impairs cognitive-motor performance in Parkinson's disease. Brain 2008, 131:3348-3360.
56. Kelly C., de Zubicaray G., Di Martino A., Copland D.A., Reiss P.T., Klein D.F., et al. L-dopa modulates functional connectivity in striatal cognitive and motor networks: a double-blind placebo-controlled study. J Neurosci 2009, 29:7364-7378.
57. Haslinger B., Erhard P., Kämpfe N., Boecker H., Rummeny E., Schwaiger M., et al. Event-related functional magnetic resonance imaging in Parkinson's disease before and after levodopa. Brain 2001, 124:558-570.
58. Rowe J.B., Hughes L., Ghosh B.C., Eckstein D., Williams-Gray C.H., Fallon S., et al. Parkinson's disease and dopaminergic therapy - differential effects on movement, reward and cognition. Brain 2008, 131:2094-2105.
59. Cools R. Dopaminergic modulation of cognitive function - implications for L-DOPA treatment in Parkinson's disease. Neurosci Biobehav Rev 2006, 30:1-23.
60. Pahwa R., Wilkinson S.B., Overman J., Lyons K.E. Preoperative clinical predictors of response to bilateral subthalamic stimulation in patients with Parkinson's disease. Stereotact Funct Neurosurg 2005, 83:80-83.
61. Asanuma K., Tang C., Ma Y., Dhawan V., Mattis P., Edwards C., et al. Network modulation in the treatment of Parkinson's disease. Brain 2006, 129:2667-2678.
62. Zaidel A., Bergman H., Ritov Y., Israel Z. Levodopa and subthalamic deep brain stimulation responses are not congruent. Mov Disord 2010, 25:2379-2386.
63. Timmermann L., Braun M., Groiss S., Wojtecki L., Ostrowski S., Krause H., et al. Differential effects of levodopa and subthalamic nucleus deep brain stimulation on bradykinesia in Parkinson's disease. Mov Disord 2008, 23:218-227.
64. Herzog J., Möller B., Witt K., Pinsker M.O., Deuschl G., Volkmann J. Influence of subthalamic deep brain stimulation versus levodopa on motor perseverations in Parkinsons's disease. Mov Disord 2009, 24:1206-1210.
65. Hartinger M., Tripoliti E., Hardcastle W.J., Limousin P. Effects of medication and subthalamic nucleus deep brain stimulation on tongue movements in speakers with Parkinson's disease using electropalatography: a pilot study. Clin Linguist Phon 2011, 25(3):210-230.